Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride. (12th September 2022)
- Record Type:
- Journal Article
- Title:
- Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride. (12th September 2022)
- Main Title:
- Experimental Study on the Inhibition of RANKL-Induced Osteoclast Differentiation In Vitro by Metformin Hydrochloride
- Authors:
- Chen, Zhang
Zige, Liu
Sai Kiang, Yeow
Desheng, Chen - Other Names:
- D'Amelio Patrizia Academic Editor.
- Abstract:
- Abstract : Objective . Establishment of an in vitro osteoclast induction model under nuclear factor- κ B receptor activator ligand (RANKL) induction for investigating the effect of metformin hydrochloride (Met) on osteoclast differentiation. Methods . RANKL induced the differentiation of mouse bone marrow macrophages (BMMs) into osteoclasts in vitro, and Met was added at different concentrations for intervention during the induction process. After 5 d of culture and fixation, the number of osteoclasts was counted by tartrate-resistant acid phosphatase (TRAP) staining and F-actin staining, and the function of osteoclasts was examined with hydroxyapatite-coated plates. Real-time fluorescence quantitative PCR was performed to detect the expression of Cathepsin K, osteoclast associated receptor ( OSCAR ), and TRAP, and the effect of Met on Mitogen-activated protein kinases (MAPK) signaling pathway was detected by Western blot. Results . Met significantly reduced osteoclast formation, F-actin ring formation, bone resorption, and the expression of relevant genes Cathepsin K, OSCAR, and TRAP . The Western blotting study demonstrated that Met inhibited the MAPK signaling pathway by decreasing the phosphorylation of extracellular regulated protein kinase (ERK), which plays important roles in osteoclast formation. Conclusion . Metformin hydrochloride inhibited the differentiation of osteoclasts, decreased the bone resorption area, and suppressed phosphorylation of ERK in vitro.
- Is Part Of:
- International journal of endocrinology. Volume 2022(2022)
- Journal:
- International journal of endocrinology
- Issue:
- Volume 2022(2022)
- Issue Display:
- Volume 2022, Issue 2022 (2022)
- Year:
- 2022
- Volume:
- 2022
- Issue:
- 2022
- Issue Sort Value:
- 2022-2022-2022-0000
- Page Start:
- Page End:
- Publication Date:
- 2022-09-12
- Subjects:
- Endocrinology -- Periodicals
Endocrinology
Endocrinology -- Periodicals
Endocrine System Diseases -- Periodicals
Periodicals
616.4 - Journal URLs:
- https://www.hindawi.com/journals/ije/ ↗
http://bibpurl.oclc.org/web/41843 ↗
http://www.ncbi.nlm.nih.gov/pmc/journals/995/ ↗ - DOI:
- 10.1155/2022/6778332 ↗
- Languages:
- English
- ISSNs:
- 1687-8337
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library HMNTS - ELD Digital store
- Ingest File:
- 23952.xml